Pharmazeutisch
COVID-19 Vaccine AstraZeneca - Product Information as approved by the CHMP on 29 January 2021, pending endorsement by the European Commission
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.